Drawing for XENOSPIN

USPTO serial 76400436

XENOSPIN

Reviewed by CopyMark Law Group

Reg. 3089031Status 710
Filing date
Status date
Registration date
May 9, 2006
Examiner
JOHNSON, AISHA CLARKE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with XENOSPIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Catherine Mennenga

CATHERINE MENNENGA GENERAL ELECTRIC COMPANY3135 EASTON TPKEFAIRFIELD, CT 06828-0001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001CHEMICALS, BIOCHEMICALS AND REAGENTS FOR USE IN INDUSTRY, SCIENCE, AND RESEARCH, NAMELY, NUCLEOTIDES, OLIGONUCLEOTIDES, PEPTIDES, PROTEINS, AMINO ACIDS, ORGANIC MOLECULES, CHEMICAL MARKERS FOR DNA AND RNA SYNTHESIS; REAGENTS FOR GENE EXPRESSION QUANTIFICATION; REAGENTS FOR USE WITH THE POLYMERASE REACTION, PCR, PROCESS AND RCA, ROLLING CIRCLE AMPLICATION PROCESS; REAGENTS FOR CDNA CLONING VECTORS, MODIFYING AND RESTRICTION ENZYMES; REAGENTS FOR LABELING, SEQUENCING AND FRAGMENT ANALYSIS OF NUCLEIC ACIDS, PROTEINS AND CUSTOM SYNTHESIS; REAGENTS FOR RECOMBINANT PROTEIN EXPRESSION PURIFICATION, CHROMATOGRAPHY MEDIA, ELECTROPHORESIS, SPECTROPHOTOMETRY AND FLUOROMETRY; RADIOCHEMICALS; SCINTILLATION ASSAYS; AND HIGH THROUGH PUT SCREENING ASSAYS FOR DRUG DEVELOPMENT; CHEMICAL PREPARATIONS AND SUBSTANCES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL PRODUCTS; DIAGNOSTIC PREPARATIONS AND SUBSTANCES FOR SCIENTIFIC AND RESEARCH USE; CHEMICAL TEST REAGENTS, SALINE SOLUTION AND REAGENT-COATED PAPER ALL FOR SCIENTIFIC AND LABORATORY USE; FISSIONABLE CHEMICAL ELEMENTS; RADIOACTIVE ELEMENTS, ISOTOPES, PREPARATIONS, AND REAGENTS FOR INDUSTRIAL, SCIENTIFIC, AND RESEARCH PURPOSES; KITS CONSISTING PRIMARILY OF CHEMICAL PREPARATIONS AND REAGENTS FOR ANALYSIS AND DIAGNOSIS USED FOR SCIENTIFIC PURPOSES, NAMELY, CELL SEPARATION AND CULTURE, NUCLEIC ACID PURIFICATION; RADIONUCLIDES; AND GASES AND GAS MIXTURES FOR INDUSTRIAL, SCIENTIFIC, AND RESEARCH PURPOSES; NONE OF THE FOREGOING FOR CLINICAL OR MEDICAL DIAGNOSTIC USESECTION 8 - CANCELLED
009Scientific apparatus and instruments for use in measuring, monitoring and surveying, namely, computers, printers, and computer software programs for use in life science research and data analysis, namely, detecting and monitoring radiation, radioactivity, and radioactive contamination, and for nuclear cardiology and medical imaging, for use by laboratories; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films, namely, automated film readers and scanners; apparatus for electrophoresis comprised of gel separation units, power/control units, gel cassettes, tanks, and casting, running and blotting modules; chromatography columns and pumps; scientific apparatus for microfabrication comprised of scanners and imagers; apparatus for scintillation imaging cameras and scintillation counters; synthesis and purification intergrated systems comprised of chromatography monitors, computer hardware and data processing software for use in radiology; imaging apparatus for radioactive emissions for use in radiology; apparatus for use in the manufacturing of oligonucleotides, comprised of synthesizers and purifiers; apparatus for microarrays, comprised of array spotters, array scanners, slide processors and hybidation buffers; microvials, and microplates for scientific purposes; and parts and fittings for the aforesaid goods; diagnostic and test kits for non-medical purposes comprised of test tubes, test plates and indicator charts for evaluating test resultsSECTION 8 - CANCELLED
010Surgical, medical, dental, and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radiotherapy, namely, medical needles, suture needles, implantable radiation therapy devices and implantable radiation therapy devices consisting of encapulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; radiological apparatus for diagnostic and medical purposes, namely, magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography apparatus, cat scan apparatus; scanners and ultrasound diagnostic apparatus; cannulas; vial access cannulas; needles and syringes for medical use; injectors for medical use; cartridges for medical use; infusion pumps for intravenous administration of fluids; diagnostic and test kits for medical use comprised of test tubes, test plates and indicator charts for evaluating test results; and parts and fittings for the aforesaid goodsSECTION 8 - CANCELLED
041Educational services, namely training services and conducting classes and seminars in the field of medical imaging and diagnostics; holding seminars, conferences, symposiums and workshops relating to the pharmaceutical industry, for medical practitioners and employees of pharmaceutical companiesSECTION 8 - CANCELLED
042PHARMACEUTICAL ANALYSIS, NAMELY, CHEMICAL ANALYSIS AND PHARMACEUTICAL RESEARCH FOR PHARMACEUTICAL COMPANIES IN THE FIELD OF PURIFICATION AND CHROMATOGRAPHY; DEVELOPMENT SERVICES IN THE FIELDS OF PHARMACEUTICALS, LIFE SCIENCES, MEDICINE AND BIOCHEMISTRY; PRODUCT RESEARCH AND DEVELOPMENT FOR OTHERS, NAMELY RESEARCH AND DEVELOPMENT OF PHARMACEUTICAL, MEDICAL, AND VETERINARY PREPARATIONS, DIAGNOSTIC MEDIA AND AGENTS FOR USE IN MEDICAL AND DIAGNOSTIC IMAGING; MEDICAL LABORATORY SERVICES, NAMELY, MEDICAL DIAGNOSTIC SERVICES, AND MEDICAL IMAGING SERVICES; RADIOLABELING SERVICES, NAMELY ISOTOPIC LABELING OF BIOLOGICAL MOLECULES; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES FOR PHARMACEUTICAL COMPANIES AND MEDICAL PROFESSIONALS; AND CHEMICAL AND PHARMACEUTICAL RESEARCH FOR PHARMACEUTICAL COMPANIES IN THE FIELD OF PURIFICATION AND CHROMATOGRAPHYSECTION 8 - CANCELLED
044PHARMACEUTICAL ADVICE AND CONSULTANCY SERVICES; PROVIDING MEDICAL INFORMATION; MEDICAL TESTING; MEDICAL IMAGING SERVICES; PROVIDING MEDICAL INFORMATION AND MEDICINAL INFORMATION, NAMELY, INFORMATION REGARDING PHARMACOLOGICAL PROPERTIES TO PHARMACEUTICAL COMPANIES AND MEDICAL PROFESSIONALSSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 14, 2012C8..CANCELLED SEC. 8 (6-YR)
May 9, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 10, 2006ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Feb 21, 2006ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 25, 2005ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Apr 26, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 6, 2005NPUBNOTICE OF PUBLICATION
Feb 7, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 12, 2005ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2005REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 30, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2004ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 14, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 15, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2004ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 1, 2004ALIEASSIGNED TO LIE
Aug 24, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 24, 2004ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 23, 2004ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jun 22, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 16, 2004MAILPAPER RECEIVED
Jun 2, 2004NPUBNOTICE OF PUBLICATION
Oct 2, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2003CFITCASE FILE IN TICRS
Aug 23, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2003CNCFCONTINUATION OF FINAL REFUSAL MAILED
Jul 29, 2003ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
May 14, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 10, 200344EASEC. 44(E) CLAIM ADDED
Jan 10, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2003MAILPAPER RECEIVED
Jan 3, 2003DOCKASSIGNED TO EXAMINER
Oct 16, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2002DOCKASSIGNED TO EXAMINER
Aug 21, 2002DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance